儿童风湿病并发肺栓塞的随访与预后分析
该回顾性病例系列研究纳入2014年1月至2023年10月首都医科大学附属首都儿童医学中心风湿免疫科收治的8例风湿病并发肺栓塞患儿,分析其临床特征、诊疗策略及预后。所有患儿均在原发病活动期发生肺栓塞,以发热为主要表现,影像学检查是诊断关键;早期采用肝素序贯华法林抗凝及糖皮质激素联合免疫抑制剂和(或)生物制剂控制原发病可获良好预后。
要点
- 儿童风湿病并发肺栓塞与原发病活动密切相关,临床表现隐匿,发热为主要表现。
- 影像学检查是诊断儿童风湿病并发肺栓塞的关键。
- 早期肝素序贯华法林抗凝及控制原发病可获良好预后。
核心结论
- 儿童风湿病并发肺栓塞与原发病活动密切相关,临床表现隐匿,以发热为主要表现,影像学检查是诊断关键,早期采用肝素序贯华法林抗凝及糖皮质激素联合免疫抑制剂和(或)生物制剂控制原发病可获良好预后。
研究设计与样本
- 回顾性病例系列研究,收集2014年1月至2023年10月首都医科大学附属首都儿童医学中心风湿免疫科收治的8例风湿病并发肺栓塞患儿的人口学资料、实验室指标、影像学特征、治疗方案及随访资料。
主要发现
- 8例患儿中男、女各4例,就诊年龄12.0(7.5,13.0)岁;原发病为系统性红斑狼疮3例、白塞病2例、多发性大动脉炎2例、抗磷脂综合征1例。
- 所有患儿均在原发病活动期发生肺栓塞,3例于首次就诊时发现,5例肺栓塞发病时间距原发病确诊时间为10.0(6.0,25.0)个月。
- 临床表现中发热8例,伴胸闷、呼吸困难等4例,2例仅表现为发热。
- 实验室检查显示红细胞沉降率42.0(17.0,78.0)mm/1 h,高敏C反应蛋白12.7(2.6,78.7)mg/L,白细胞计数9.6(7.2,18.7)×10⁹/L,D二聚体2.3(0.9,6.2)mg/L,血红蛋白(109±16)g/L。
- 影像学检查示双下肺动脉受累5例,周围型栓塞5例,中心型肺栓塞3例;3例合并深静脉血栓,2例伴颅内静脉窦血栓,1例轻度肺动脉高压。
关键数值与推荐
- 7例患儿采用肝素序贯华法林抗凝,免疫调节以糖皮质激素联合免疫抑制剂为主,4例联用生物制剂。
- 随访4.17(1.75,7.17)年,所有患儿肺栓塞完全吸收时间为10.5(6.0,18.0)个月。
- 8例患儿经随访均无目标事件发生,无复发或慢性血栓栓塞性肺动脉高压,肺动脉重构良好。
临床怎么用
- 对风湿病活动期患儿应警惕肺栓塞,发热为主要表现时需结合影像学检查早期诊断。
- 确诊后早期采用肝素序贯华法林抗凝,并积极以糖皮质激素联合免疫抑制剂和(或)生物制剂控制原发病。
局限性
- 本研究为单中心回顾性病例系列研究,样本量仅8例,结果需更大样本研究验证。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Objective: To explore the clinical characteristics, diagnosis and treatment strategies, and prognosis of pulmonary embolism (PE) complicating childhood rheumatic diseases. Methods: A retrospective case series study was performed on the demographic data, laboratory indicators, imaging features, treatment regimens, and follow-up data of 8 children with rheumatic diseases complicated by PE who were admitted to the Department of Rheumatology and Immunology, Capital Center for Children's Health, Capital Medical University from January 2014 to October 2023. Results: Among the 8 children, there were 4 boys and 4 girls, with an age of 12.0 (7.5, 13.0) years. Among the primary diseases, there were 3 cases of systemic lupus erythematosus, 2 cases of Behçet's disease, 2 cases of Takayasu arteritis, and 1 case of antiphospholipid syndrome. All children developed PE during the active phase of the primary disease. PE was detected at the onset of the primary disease in 3 cases, and the median time from the diagnosis of the primary disease to the development of PE was 10.0 (6.0, 25.0) months in the remaining 5 cases. Fever was present in all 8 children, 4 cases were accompanied by chest tightness, dyspnea, etc., and 2 cases only presented with fever. Laboratory examinations revealed the following results: erythrocyte sedimentation rate was 42.0 (17.0, 78.0) mm/1 h, high-sensitivity C-reactive protein was 12.7 (2.6, 78.7) mg/L, white blood cell count was 9.6 (7.2, 18.7)×109/L; D-dimer was 2.3 (0.9, 6.2) mg/L; and hemoglobin was (109±16) g/L.Imaging examinations revealed that 5 cases had involvement of the bilateral lower pulmonary arteries, 5 cases had peripheral embolism, and 3 cases had central PE. Complications included 3 cases of deep vein thrombosis, 2 cases of intracranial venous sinus thrombosis, and 1 case of mild pulmonary hypertension.In terms of treatment, 7 cases received anticoagulation with heparin followed by warfarin. Immunomodulation was mainly based on glucocorticoids combined with immunosuppressants, and 4 cases were combined with biological agents. The follow-up time of 4.17 (1.75, 7.17) years, the time for complete absorption of PE was 10.5 (6.0, 18.0) months; all 8 children had no target events, with no recurrence or chronic thromboembolic pulmonary hypertension, and the pulmonary artery remodeling was good. Conclusions: PE complicating childhood rheumatic diseases is closely related to the activity of the primary disease. The clinical manifestations are insidious, with fever as the main symptom. Imaging examination is the key to diagnosis.Early adoption of heparin followed by warfarin anticoagulation and glucocorticoids combined with immunosuppressants and (or) biological agents to control the primary disease can achieve a favorable prognosis. 目的: 探讨儿童风湿病并发肺栓塞的临床特征、诊疗策略及预后。 方法: 回顾性病例系列研究,收集2014年1月至2023年10月首都医科大学附属首都儿童医学中心风湿免疫科收治的8例风湿病并发肺栓塞患儿的人口学资料、实验室指标、影像学特征、治疗方案及随访资料。 结果: 8例患儿中,男、女各4例,就诊年龄12.0(7.5,13.0)岁。8例患儿原发病中系统性红斑狼疮3例,白塞病2例、多发性大动脉炎2例、抗磷脂综合征1例。所有患儿均在原发病活动期发生肺栓塞,3例患儿于首次就诊时发现,5例患儿肺栓塞的发病时间距原发病确诊时间为10.0(6.0,25.0)个月。临床表现中发热8例,伴胸闷、呼吸困难4例等,2例患儿仅表现为发热。实验室检查显示8例患儿中红细胞沉降率42.0(17.0,78.0)mm/1 h,高敏C反应蛋白12.7(2.6,78.7)mg/L,白细胞计数9.6(7.2,18.7)×10⁹/L;D二聚体2.3(0.9,6.2)mg/L;血红蛋白(109±16)g/L。影像学检查示8例患儿中双下肺动脉受累5例,周围型栓塞5例,中心型肺栓塞3例;3例患儿合并深静脉血栓,2例伴颅内静脉窦血栓,1例轻度肺动脉高压。治疗方面7例患儿采用肝素序贯华法林抗凝,免疫调节以糖皮质激素联合免疫抑制剂为主,4例联用生物制剂。随访4.17(1.75,7.17)年,所有患儿肺栓塞完全吸收时间为10.5(6.0,18.0)个月,8例患儿经随访,均无目标事件发生,无复发或慢性血栓栓塞性肺动脉高压,肺动脉重构良好。 结论: 儿童风湿病并发肺栓塞与原发病活动密切相关,临床表现隐匿,以发热为主要表现,影像学检查是诊断关键,早期采用肝素序贯华法林抗凝及糖皮质激素联合免疫抑制剂和(或)生物制剂控制原发病可获良好预后。.
引用
- Yue T, Yan YC, Kang M, et al. [Analysis of follow-up and prognosis in pediatric rheumatic diseases associated with pulmonary embolism]. Zhonghua Er Ke Za Zhi. 2026. PMID: 41401925. doi:10.3760/cma.j.cn112140-20250714-00613
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。